GB0413726D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0413726D0
GB0413726D0 GBGB0413726.1A GB0413726A GB0413726D0 GB 0413726 D0 GB0413726 D0 GB 0413726D0 GB 0413726 A GB0413726 A GB 0413726A GB 0413726 D0 GB0413726 D0 GB 0413726D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0413726.1A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lauras AS
Original Assignee
Lauras AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lauras AS filed Critical Lauras AS
Priority to GBGB0413726.1A priority Critical patent/GB0413726D0/en
Publication of GB0413726D0 publication Critical patent/GB0413726D0/en
Priority to EP05755520.3A priority patent/EP1765844B1/en
Priority to DK05755520.3T priority patent/DK1765844T3/da
Priority to JP2007516050A priority patent/JP5044750B2/ja
Priority to PCT/GB2005/002418 priority patent/WO2005123755A2/en
Priority to US11/629,908 priority patent/US8153609B2/en
Priority to ES05755520.3T priority patent/ES2496946T3/es
Priority to AU2005254790A priority patent/AU2005254790B2/en
Priority to CA2568907A priority patent/CA2568907C/en
Priority to CNA2005800259528A priority patent/CN101001865A/zh
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C07H19/213—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids containing cyclic phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
GBGB0413726.1A 2004-06-18 2004-06-18 Compounds Ceased GB0413726D0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GBGB0413726.1A GB0413726D0 (en) 2004-06-18 2004-06-18 Compounds
CNA2005800259528A CN101001865A (zh) 2004-06-18 2005-06-20 嘌呤核苷酸衍生物
PCT/GB2005/002418 WO2005123755A2 (en) 2004-06-18 2005-06-20 Purine nucleotide derivatives
DK05755520.3T DK1765844T3 (da) 2004-06-18 2005-06-20 Purin-nukleotidderivater
JP2007516050A JP5044750B2 (ja) 2004-06-18 2005-06-20 プリンヌクレオチド誘導体
EP05755520.3A EP1765844B1 (en) 2004-06-18 2005-06-20 Purine nucleotide derivatives
US11/629,908 US8153609B2 (en) 2004-06-18 2005-06-20 Purine nucleotide derivatives
ES05755520.3T ES2496946T3 (es) 2004-06-18 2005-06-20 Derivados de nucleótidos de purina
AU2005254790A AU2005254790B2 (en) 2004-06-18 2005-06-20 Purine nucleotide derivatives
CA2568907A CA2568907C (en) 2004-06-18 2005-06-20 8-carbyl substituted cyclic adenosine-3',5'-monophosphorothiolate compounds as camp modulators

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0413726.1A GB0413726D0 (en) 2004-06-18 2004-06-18 Compounds

Publications (1)

Publication Number Publication Date
GB0413726D0 true GB0413726D0 (en) 2004-07-21

Family

ID=32750205

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0413726.1A Ceased GB0413726D0 (en) 2004-06-18 2004-06-18 Compounds

Country Status (10)

Country Link
US (1) US8153609B2 (https=)
EP (1) EP1765844B1 (https=)
JP (1) JP5044750B2 (https=)
CN (1) CN101001865A (https=)
AU (1) AU2005254790B2 (https=)
CA (1) CA2568907C (https=)
DK (1) DK1765844T3 (https=)
ES (1) ES2496946T3 (https=)
GB (1) GB0413726D0 (https=)
WO (1) WO2005123755A2 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007006544A2 (en) * 2005-07-12 2007-01-18 Vrije Universiteit Brussel Cyclic adenosine monophosphate compounds for the treatment of immune-related disorders
GB0618235D0 (en) * 2006-09-15 2006-10-25 Lauras As Process
PT2448968T (pt) * 2009-06-29 2021-04-30 Bioarctic Ab ANTICORPOS SELETIVOS PARA PROTOFIBRILAS/OLIGÓMEROS DE ß- AMILOIDE TRUNCADA EM N-TERMINAL
BR112013005872A2 (pt) 2010-09-22 2019-09-24 Alios Biopharma Inc compostos, composição farmacêutica e respectivos usos
AU2011349278C1 (en) * 2010-12-22 2017-01-19 Alios Biopharma, Inc. Cyclic nucleotide analogs
EP2794630A4 (en) 2011-12-22 2015-04-01 Alios Biopharma Inc SUBSTITUTED PHOSPHORTHIOAT NUCLEOTIDE ANALOGUE
UA117095C2 (uk) 2011-12-22 2018-06-25 Аліос Біофарма, Інк. Нуклеозидна сполука або її фармацевтично прийнятна сіль
US9441007B2 (en) 2012-03-21 2016-09-13 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
USRE48171E1 (en) 2012-03-21 2020-08-25 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
WO2013142124A1 (en) 2012-03-21 2013-09-26 Vertex Pharmaceuticals Incorporated Solid forms of a thiophosphoramidate nucleotide prodrug
US9012427B2 (en) 2012-03-22 2015-04-21 Alios Biopharma, Inc. Pharmaceutical combinations comprising a thionucleotide analog
US20240182511A1 (en) * 2021-04-09 2024-06-06 Merck Sharp & Dohme Llc Novel forms of cyclic dinucleotide compounds
EP4399215A1 (en) 2021-09-06 2024-07-17 Mireca Medicines GmbH Improved methods for production of cyclic guanosine-monophosphate analogues

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3968101A (en) 1974-12-20 1976-07-06 Icn Pharmaceuticals, Inc. 8-Substituted cyclic nucleotides by free radical alkylation and acylation
WO1989007108A1 (en) * 1988-02-01 1989-08-10 Bernd Jastorff Process for producing nucleoside-3',5'-cyclophosphates and nucleoside-3',5'-cyclothiophosphates
AU4226693A (en) 1992-05-01 1993-11-29 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Phosphorothioate derivatives of cyclic AMP analogues
US5625056A (en) 1992-05-26 1997-04-29 Biolog Life Science Institute Derivatives of cyclic guanosine-3',5'-monophosphorothioate
NO971997D0 (no) 1997-04-29 1997-04-29 Kjetil Tasken Bruk av immunmodulerende midler
EP1511757B1 (en) * 2002-06-07 2015-11-04 Universitair Medisch Centrum Utrecht New compounds for modulating the activity of exchange proteins directly activated by camp (epacs)

Also Published As

Publication number Publication date
ES2496946T3 (es) 2014-09-22
CN101001865A (zh) 2007-07-18
JP5044750B2 (ja) 2012-10-10
WO2005123755A2 (en) 2005-12-29
CA2568907A1 (en) 2005-12-29
US8153609B2 (en) 2012-04-10
AU2005254790B2 (en) 2012-02-23
AU2005254790A1 (en) 2005-12-29
EP1765844A2 (en) 2007-03-28
JP2008502673A (ja) 2008-01-31
DK1765844T3 (da) 2014-09-01
US20080293665A1 (en) 2008-11-27
EP1765844B1 (en) 2014-07-30
WO2005123755A3 (en) 2006-04-06
CA2568907C (en) 2015-06-09

Similar Documents

Publication Publication Date Title
GB0405933D0 (en) Compounds
GB0405937D0 (en) Compounds
GB0405193D0 (en) Compounds
GB0413726D0 (en) Compounds
GB0405272D0 (en) Compounds
GB0401269D0 (en) Compounds
GB0405267D0 (en) Compounds
GB0405101D0 (en) Compounds
GB0408777D0 (en) Compounds
GB0408772D0 (en) Compounds
GB0405280D0 (en) Compounds
GB0403593D0 (en) Compounds
GB0405893D0 (en) Compounds
GB0406916D0 (en) Compounds
GB0403595D0 (en) Compounds
GB0406915D0 (en) Compounds
GB0403990D0 (en) Compounds
GB0403334D0 (en) Compounds
GB0403267D0 (en) Compounds
GB0408774D0 (en) Compounds
GB0401657D0 (en) Compounds
GB0406963D0 (en) Compounds
GB0406918D0 (en) Compounds
GB0401656D0 (en) Compounds
GB0403998D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)